CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
about
CB2 Cannabinoid Receptor As Potential Target against Alzheimer's DiseaseCannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of NeuroinflammationNew approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?
P2860
CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
CB₂ receptor deficiency increa ...... model of Alzheimer's disease.
@en
CB₂ receptor deficiency increa ...... model of Alzheimer's disease.
@nl
type
label
CB₂ receptor deficiency increa ...... model of Alzheimer's disease.
@en
CB₂ receptor deficiency increa ...... model of Alzheimer's disease.
@nl
prefLabel
CB₂ receptor deficiency increa ...... model of Alzheimer's disease.
@en
CB₂ receptor deficiency increa ...... model of Alzheimer's disease.
@nl
P2093
P2860
P1433
P1476
CB₂ receptor deficiency increa ...... e model of Alzheimer's disease
@en
P2093
Cristina d'Abramo
Heidy Jimenez
Jeremy Koppel
Mark Stauber
Peter Davies
Rachel Friedman
P2860
P2888
P304
P356
10.2119/MOLMED.2013.00140
P407
P577
2013-11-08T00:00:00Z
P6179
1068965638